Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · IEX Real-Time Price · USD
14.58
+0.20 (1.39%)
At close: May 31, 2024, 4:00 PM
14.56
-0.02 (-0.14%)
After-hours: May 31, 2024, 7:50 PM EDT
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for SBRA stock have an average target of 15.65, with a low estimate of 12.5 and a high estimate of 21. The average target predicts an increase of 7.34% from the current stock price of 14.58.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SBRA stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 6 | 6 | 6 | 6 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 7 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Hold Maintains $14 → $15 | Hold | Maintains | $14 → $15 | +2.88% | May 15, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +44.03% | Jan 30, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +16.60% | Jan 3, 2024 |
| Stifel | Stifel | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +9.74% | Nov 7, 2023 |
| Wells Fargo | Wells Fargo | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | +2.88% | Oct 17, 2023 |
Financial Forecast
Revenue This Year
672.07M
from 647.51M
Increased by 3.79%
Revenue Next Year
703.58M
from 672.07M
Increased by 4.69%
EPS This Year
0.58
from 0.06
Increased by 864.75%
EPS Next Year
0.64
from 0.58
Increased by 10.57%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 718.4M | 778.5M | 825.3M | 876.2M | 928.0M |
| Avg | 672.1M | 703.6M | 746.2M | 851.2M | 901.5M |
| Low | 623.0M | 649.5M | 663.7M | 817.8M | 866.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.0% | 15.8% | 17.3% | 17.4% | 9.0% |
| Avg | 3.8% | 4.7% | 6.1% | 14.1% | 5.9% |
| Low | -3.8% | -3.4% | -5.7% | 9.6% | 1.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.61 | 0.72 | 0.68 |
| Avg | 0.58 | 0.64 | 0.66 |
| Low | 0.54 | 0.57 | 0.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 915.0% | 25.2% | 6.6% |
| Avg | 864.8% | 10.6% | 3.6% |
| Low | 798.3% | -1.8% | -0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.